Global Microfluidics Technology Market 2024-2028
Microfluidics Technology Market 2024-2028
The microfluidics technology market is forecasted to grow by USD 31474.9 mn during 2023-2028, accelerating at a CAGR of 20.28% during the forecast period. The report on the microfluidics technology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing applications in molecular biology, advances in DNA sequencing increases use of microfluidic techniques, and rise in cancer incidences demands novel methods of diagnosis and drug delivery.
Technavio's microfluidics technology market is segmented as below:
By Material
- Polymer-based microfluidics
- Glass-based microfluidics
- Silicon-based microfluidics
- Others
By End-user
- Hospitals
- Diagnostic centers
- Academic institutes
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the growing use of microfluidics technology in cosmetics as one of the prime reasons driving the microfluidics technology market growth during the next few years. Also, emerging loc technology and increasing applications of microfluidics in drug delivery technologies will lead to sizable demand in the market.
The report on the microfluidics technology market covers the following areas:
- Microfluidics technology market sizing
- Microfluidics technology market forecast
- Microfluidics technology market industry analysis
The vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading microfluidics technology market vendors that include Agilent Technologies Inc., Becton Dickinson and Co., Bio RAD Laboratories Inc., Biocartis NV, BioFluidix GmbH, Blacktrace Holdings Ltd., Cellix Ltd., Danaher Corp., Elveflow, Epigem Ltd., F. Hoffmann La Roche Ltd., Fluigent SA, iBiochips, IDEX Corp., Illumina Inc., Perkin Elmer Inc., QIAGEN NV, SMC Corp., Standard BioTools Inc., and Thermo Fisher Scientific Inc.. Also, the microfluidics technology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The company presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.